Planar-based measurements of lesions in metastatic melanoma have limitations in estimating tumor burden of a patient and in predicting response to treatment. Volumetric imaging might add predictive value to Response criteria in Solid Tumor (RECIST)-measurement. | Correlation between initial tumour volume and treatment duration on Dabrafenib Observation study of subjects with BRAF mutant melanoma on the BRF112680 trial